Close

 

Fund Holdings (%)1,2 as of Dec 31, 2024

Holding % of Net Assets
Eli Lilly & Co 9.83%
UnitedHealth Group Inc 7.80%
AbbVie Inc 5.69%
Novo Nordisk A/S 5.24%
AstraZeneca PLC 4.26%
Intuitive Surgical Inc 4.12%
Thermo Fisher Scientific Inc 3.86%
Roche Holding AG 3.71%
Bristol-Myers Squibb Co 3.65%
Johnson & Johnson 3.51%
Abbott Laboratories 3.33%
Zoetis Inc 3.00%
Boston Scientific Corp 2.99%
Danaher Corp 2.90%
Vertex Pharmaceuticals Inc 2.43%
Sanofi 2.34%
Gilead Sciences Inc 2.24%
CSL Ltd 2.16%
McKesson Corp 1.68%
Neurocrine Biosciences Inc 1.52%
Merck & Co Inc 1.51%
IDEXX Laboratories Inc 1.46%
Lonza Group AG 1.44%
Mettler-Toledo International Inc 1.41%
Cooper Cos Inc 1.27%
ARGENX SE - ADR 1.20%
Edwards Lifesciences Corp 1.19%
Stryker Corp 1.15%
Alcon AG 1.13%
Centene Corp 1.07%
SPDR S&P Biotech ETF 1.01%
Teleflex Inc 0.98%
Straumann Holding AG 0.97%
Coloplast A/S 0.96%
Royalty Pharma PLC 0.88%
Amplifon SpA 0.87%
Illumina Inc 0.86%
AptarGroup Inc 0.75%
Sartorius AG 0.73%
Align Technology Inc 0.71%
Neogen Corp 0.55%
Option Care Health Inc 0.45%
Asahi Intecc Co Ltd 0.45%
Newamsterdam Pharma Co NV 0.32%
JMDC Inc 0.22%
CARIS LIFE SCIENCES, INC 0.06%
MSILF GOVERNMENT PORTFOLIO 0.04%